Evommune, Inc.
NYSE:EVMNBiotechnology
Healthcare
$6.88 -0.82%
-$0.17 today
- Market cap
- $284.49M
- Beta
- 0.10
- P/E (TTM)
- -9.1
- EPS (TTM)
- -$2.26
52W Low $13.89High $33.20
Volume 0.60M
Average 0.38M
Balance Sheet
Inspect the capital base behind the business.
Assets
$224.95M
FY 2025 · Annual
+195.8% YoYLiabilities
$19.38M
FY 2025 · Annual
-91.2% YoYEquity
$205.57M
FY 2025 · Annual
Balance Sheet
USD
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $48.3M |
| Short-term Investments | $163.1M |
| Other Current | $4.4M |
| Total Current Assets | $215.9M |
| PP&E (Net) | $9.6M |
| Goodwill | $818.1K |
| Intangible Assets | $1.4M |
| Long-term Investments | $97.0M |
| Other Non-current | -$2.1M |
| Total Non-current Assets | $106.6M |
| Total Assets | $322.5M |
Analysis
Selected assets total $322.5M for Latest. The largest visible component is Short-term Investments at $163.1M, about 50.6% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 424B3 | 424B3 filing | Nov 12, 2026 | |
| 8-K | Current report | Nov 12, 2026 | |
| 10-Q | Quarterly report | Nov 12, 2026 | |
| SC 13D/A | SC 13D/A filing | Nov 10, 2026 | |
| 8-K | Current report | Nov 5, 2026 |
How much cash does EVMN have?
Evommune, Inc. (EVMN) reported $44.06M in cash and equivalents in fiscal 2025.
How much debt does EVMN carry?
Evommune, Inc. (EVMN) reported $2.06M of total debt, with net debt of -$42.00M.
Continue the stock analysis
Jump to another research area for this company.